
In upcoming weeks, I will be publishing a conversation I had with NitroMed on this topic. NitroMed makes BiDil, the first medication ever approved for the treatment of a specific racial group: self-identified African Americans with heart failure.
Click here to read a press release on this series. Click here to read the interviews. I will publish the final four conversations on Envisioning 2.0 in April and May.








Comment Preview